USA TODAY on MSN12d
Here's why researchers think most people stop taking weight loss drugs within a year
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
Fin vs Fin on MSN1y
Semaglutide vs. Liraglutide vs. Tirzepatide: What's the Difference for Weight Loss?
Side effects are similar between the three medications, but liraglutide is the most likely to cause psychiatric side effects.
AOL1mon
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
Novo Nordisk warns that adding liraglutide to the 503B Bulks List would contradict Congress’ and the FDA’s intent to restrict patient exposure to unapproved drugs.
Lexaria’s Human GLP-1 Study #5 Receives Independent Review Board Approval
Detailed price information for Lexaria Bioscience Corp WT (LEXXW-Q) from The Globe and Mail including charting and trades.